Global Hyperbaric Oxygen Therapy (HBOT) Market, By Product Type (Monoplace HBOT, Multiplace HBOT and Topical HBOT devices), Application (Wound Healing, Decompression Sickness, Infection Treatment, Gas Embolism and Others), End-Use (Hospitals and Clinics, Ambulatory Surgery Centres and Others) – Industry Trends and Forecast to 2029.
Hyperbaric Oxygen Therapy (HBOT) Market Analysis and Size
According to the Centers for Disease Control and Prevention (CDC), over 30 million Americans had diabetes in 2017. Increased blood oxygen levels brought on by HBOT aid in the development of vessels, which is essential for people with diabetes. As a result, the market for hyperbaric oxygen therapy is growing. Due to the significant increase in the frequency of wounds and injuries brought on by the growing popularity of adventure sports, physiotherapists now advise HBOT for serious wounds.
Data Bridge Market Research analyses that the hyperbaric oxygen therapy (HBOT) market, which was USD 3.39 billion in 2021, would rocket up to USD 6.96 billion by 2029, and is expected to undergo a CAGR of 9.40% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Hyperbaric Oxygen Therapy (HBOT) Market Scope and Segmentation
2022 to 2029
2020 (Customizable to 2014 - 2019)
Revenue in USD Billion, Volumes in Units, Pricing in USD
Product Type (Monoplace HBOT, Multiplace HBOT and Topical HBOT devices), Application (Wound Healing, Decompression Sickness, Infection Treatment, Gas Embolism and Others), End-Use (Hospitals and Clinics, Ambulatory Surgery Centres and Others)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
Perry Baromedical (U.S.), Sechrist Industries, Inc. (U.S.), Tekna Hyperbaric (India), Pan America Hyperbarics, Inc. (U.S.), HAUX-LIFE-SUPPORT (Germany), PCCI (France), Hipertech Electronics Inc. (U.S.), Sosgroup (U.S.), HEARMEC (France), OxyHealth (U.S.), Environmental Tectonics Corporation (U.S.), IHC Merwede Holding B.V. (Netherlands), Advanced Biomedical Engineering (Japan), Airox Technologies Private Limited (India), Biovision Healthcare (India), Richmond Hyperbaric Health Center (Canada), Universe Surgical Equipment Co. (India)
A medical device called hyperbaric oxygen therapy (HBOT) delivers the ideal amount of oxygen to the body's tissues when the atmosphere is at a high pressure. This medical procedure raises air pressure two to three times over normal air pressure. As a result, the oxygen-carrying blood aids in the body's fight against bacteria and other undesirable hosts by nurturing healing. This medical procedure is used to treat radiation-related wounds, blood vessel air bubbles, and numerous other dangerous infections like diabetes.
Hyperbaric Oxygen Therapy (HBOT) Market Dynamics
- Increasing number of diabetic patients
The rise in demand for devices for hyperbaric oxygen therapy is the rising number of diabetic patients worldwide. As a result, the market will have an upward tendency over time. Additionally, the market is anticipated to grow as medical tourism rises. The government's support and investment in the growing factors in the healthcare industry cannot be disregarded for the increase in demand. Additionally, this technique is now used to treat cancer patients as well as individuals with brain injuries.
- Raising patient awareness of HBOT
The market is expected to grow faster than average because to the increased prevalence of diabetes. On the other side, raising patient awareness of HBOT can favor the market's expansion. The rise in chronic wound cases may also fuel market expansion during the forecast period.
- Rise in the geriatric population
The rising prevalence rates of lifestyle disorders like as diabetes and obesity, rising health-care spending, and the fast-growing diagnostic industry are driving the hyperbaric oxygen therapy (HBOT) market expansion.
The HBOT market is extending its applications due to the escalating technological developments. For instance, its uses in treating AIDS, Parkinson's disease, Alzheimer's disease, multiple sclerosis, and other conditions may increase market expansion.
The exorbitant price of the entire setup would hinder HBOT's market expansion. Lack of knowledge regarding these systems may also act as a roadblock to the expansion of this sector. The potential negative effects of the medication are another market constraint. These include visual abnormalities, sinus problems, oxygen deprivation, etc.
This hyperbaric oxygen therapy (HBOT) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hyperbaric oxygen therapy (HBOT) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Hyperbaric Oxygen Therapy (HBOT) Market
The COVID-19 epidemic had a negative impact on society and the economy. The pandemic has impacted numerous organisations' supply chains and value chains. The market for clinics offering hyperbaric oxygen treatment (HBOT) is not an exception. The impact of the COVID-19 pandemic will be examined based on the entire industry, considering both the demand and supply side viewpoints. The pandemic's consequences would be researched and examined for both short- and long-term situations.
- In November 2019, At the MEDICA trade fair in Germany, AHA Hyperbarics GmbH unveiled the AHA Flex V2 hyperbaric system. The AHA Flex V2 hyperbaric system is used to treat diabetic foot ulcers, crush injuries, and cerebrovascular insult (CVI). This grid-powered device, which consists of two bags, operates on a 2.0 bar.
- In February 2020, Environmental Tectonics Corporation Biomedical Systems' hyperbaric segment was purchased by Perry Baromedical Corporation. Perry Baromedical Corporation expanded and penetrated markets in the Asia-Pacific region thanks to the acquisition. Additionally, the acquisition improved the installed base both domestically and internationally.
Global Hyperbaric Oxygen Therapy (HBOT) Market Scope
The hyperbaric oxygen therapy (HBOT) market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Monoplace HBOT
- Topical HBOT
- Multiplace HBOT
- Wound Healing
- Decompression Sickness
- Infection Treatment
- Gas Embolism
- Ambulatory Surgery Centres
Hyperbaric Oxygen Therapy (HBOT) Market Regional Analysis/Insights
The hyperbaric oxygen therapy (HBOT) market is analysed and market size insights and trends are provided by country, product type, application and end-user as referenced above.
The countries covered in the hyperbaric oxygen therapy (HBOT) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America holds the major share in the hyperbaric oxygen therapy (HBOT) market due to the presence of competitors with technological advancements is the major reason for the continuous growth.
Asia-Pacific looks promising and therefore would exhibit the highest CAGR, this is because of the growing number of patients with acute and chronic diseases and other health problems like diabetes, asthma, etc.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Hyperbaric Oxygen Therapy (HBOT) Market Share Analysis
The hyperbaric oxygen therapy (HBOT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to hyperbaric oxygen therapy (HBOT) market.
Some of the major players operating in the hyperbaric oxygen therapy (HBOT) market are:
- Perry Baromedical (U.S.)
- Sechrist Industries, Inc. (U.S.)
- Tekna Hyperbaric (India)
- Pan America Hyperbarics, Inc. (U.S.)
- HAUX-LIFE-SUPPORT (Germany)
- PCCI (France)
- Hipertech Electronics Inc. (U.S.)
- Sosgroup (U.S.)
- HEARMEC (France)
- OxyHealth (U.S.)
- Environmental Tectonics Corporation (U.S.)
- IHC Merwede Holding B.V. (Netherlands)
- Advanced Biomedical Engineering (Japan)
- Airox Technologies Private Limited (India)
- Biovision Healthcare (India)
- Richmond Hyperbaric Health Center (Canada)
- Universe Surgical Equipment Co. (India)